inox
Senior Member (Voting Rights)
That’s great. Well done to all who donated, fundraised or in some way were involved. I think I would have preferred the money wasn’t restricted to clinical trials/symptoms relief. I think it’s important to work out the biology so we have a better understanding of what is involved, what drugs might be required, what objective measures could be used to measure clinical response, etc.
I do agree, overall, but think this is just this years focus for applications?

And I think it's good, to stimulate some research in symptoms relief now. Norwegian patients have problems with for instance access to pain and sleep clinics, as there is no evidence base for such treatments. Even getting to try out B12 and saline can be hard, for the same reason. It would have been good to know, one way or the other, if some of these things could help a bit, as any real treatment realisticly is years away. Or just to get some of the severe patients some deasent pain relife.
Also, I think it's a wise choice, for this years grants. To both generate continuing interest into donate to research, to this year focus on somehing that might be helpfull in a shorter timespan. And to keep up patients morals, as many people feel quite down over the negative rituximab result and the thought that there is no help coming for years yet.